bosentan anhydrous has been researched along with Right Ventricular Dysfunction in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castel, MÁ; Farrero, M; García-Álvarez, A; Ivey-Miranda, JB; Perez-Villa, F; Rios, J; Santiago-Vacas, E | 1 |
| Bresser, P; Kloek, JJ; Marcus, JT; Reesink, HJ; Surie, S; van der Plas, MN; Vonk-Noordegraaf, A | 1 |
| Choudhary, G; Harrington, EO; Klinger, JR; Martin, D; Troncales, F | 1 |
| Catrina, D; Coman, IM; Dima, L; Ghiorghiu, I; Ginghina, C; Giusca, S; Jurcut, R; Popescu, BA | 1 |
| Emoto, N; Fukuda, Y; Hirata, K; Kawai, H; Motoji, Y; Ryo, K; Tanaka, H | 1 |
| Chin, KM; Kim, NH; Rubin, LJ | 1 |
| Brauchlin, AE; Nicod, LP; Rochat, T; Soccal, PM; Spiliopoulos, A; Trindade, PT | 1 |
| Naeije, R | 1 |
| Beer, M; Ertl, G; Geier, O; Hahn, D; Sandstede, J; Schmidt, M; Spindler, M | 1 |
| Comín, J; Gallardo, F; Gil, A; Iglesias, M; Molina, L; Pujol, RM | 1 |
| Bobbo, F; Cozzi, F; Durigon, N; Iliceto, S; Marotta, H; Montisci, R; Ruscazio, M; Sfriso, P; Todesco, S | 1 |
| Gabbay, E; Reed, A; Williams, TJ | 1 |
| Boonstra, A; Bronzwaer, JG; Gan, CT; Holverda, S; Marcus, JT; Marques, KM; Paulus, WJ; Postmus, PE; Twisk, JW; Vonk-Noordegraaf, A | 1 |
| Almeida, AR; Almeida, S; Carrageta, M; Cordeiro, P; Cotrim, C; Loureiro, MJ; Miranda, R; Simões, O | 1 |
| Batyraliev, TA; Ekinsi, E; Makhmutkhodzhaev, SA; Pataraia, SA; Pershukov, IV; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Chin, KM; de Lemos, JA; Kingman, M; Peshock, R; Reimold, S; Torres, F; Warner, JJ | 1 |
4 review(s) available for bosentan anhydrous and Right Ventricular Dysfunction
| Article | Year |
|---|---|
The right ventricle in pulmonary hypertension.
Topics: Bosentan; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Epoprostenol; Female; Heart Failure; Heart Function Tests; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Prognosis; Risk Assessment; Severity of Illness Index; Stroke Volume; Sulfonamides; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function | 2005 |
Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease.
Topics: Antihypertensive Agents; Bosentan; Humans; Hypertension, Pulmonary; Piperazines; Pulmonary Disease, Chronic Obstructive; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents; Ventricular Dysfunction, Right | 2005 |
Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006.
Topics: Adolescent; Adult; Aged; Arterioles; Australia; Bosentan; Cardiac Catheterization; Diagnostic Imaging; Disease Progression; Dyspnea; Endothelin A Receptor Antagonists; Epoprostenol; Exercise Test; Female; Forecasting; Heart-Lung Transplantation; Humans; Hypertension, Pulmonary; Iloprost; Lung Transplantation; Male; Middle Aged; Nitric Oxide; Piperazines; Prognosis; Pulmonary Artery; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfonamides; Sulfones; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2007 |
[Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension].
Topics: Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Isoxazoles; Phenylpropionates; Pyridazines; Sulfonamides; Thiophenes; Ventricular Dysfunction, Right | 2007 |
3 trial(s) available for bosentan anhydrous and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.
Topics: Aged; Antihypertensive Agents; Bosentan; Endarterectomy; Exercise Test; Exercise Tolerance; Female; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Netherlands; Pilot Projects; Pulmonary Embolism; Recovery of Function; Single-Blind Method; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Waiting Lists | 2013 |
Right ventricular function predicts clinical response to specific vasodilator therapy in patients with pulmonary hypertension.
Topics: Adult; Bosentan; Echocardiography; Female; Humans; Hypertension, Pulmonary; Male; Piperazines; Purines; Reproducibility of Results; Sensitivity and Specificity; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right | 2013 |
Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.
Topics: Adult; Antihypertensive Agents; Blood Circulation; Blood Pressure; Bosentan; Epoprostenol; Female; Heart Ventricles; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging; Male; Middle Aged; Nitric Oxide; Piperazines; Purines; Severity of Illness Index; Sildenafil Citrate; Stroke Volume; Sulfonamides; Sulfones; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2007 |
9 other study(ies) available for bosentan anhydrous and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Initial experience with bosentan for the management of pulmonary hypertension after heart transplantation.
Topics: Antihypertensive Agents; Bosentan; Disease Management; Female; Follow-Up Studies; Heart Transplantation; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Right | 2018 |
Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of pulmonary hypertension.
Topics: Animals; Antihypertensive Agents; Bosentan; Collagen; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Myocardium; Protein Isoforms; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Sulfonamides; Ventricular Dysfunction, Right | 2011 |
Efficacy of right ventricular free-wall longitudinal speckle-tracking strain for predicting long-term outcome in patients with pulmonary hypertension.
Topics: Aged; Antihypertensive Agents; Bosentan; Echocardiography, Doppler; Epoprostenol; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension, Pulmonary; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Predictive Value of Tests; Prognosis; ROC Curve; Sensitivity and Specificity; Sulfonamides; Vasodilator Agents; Ventricular Dysfunction, Right | 2013 |
Severe left ventricular dysfunction secondary to primary pulmonary hypertension: bridging therapy with bosentan before lung transplantation.
Topics: Adult; Antihypertensive Agents; Bosentan; Combined Modality Therapy; Humans; Hypertension, Pulmonary; Lung Transplantation; Male; Severity of Illness Index; Sulfonamides; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2005 |
Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension.
Topics: Antihypertensive Agents; Bosentan; Humans; Hypertension, Pulmonary; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphates; Pulmonary Wedge Pressure; Stroke Volume; Sulfonamides; Ventricular Dysfunction, Right; Ventricular Function, Right | 2005 |
Persistent painful indurated erythema secondary to bosentan.
Topics: Adult; Antihypertensive Agents; Bosentan; Erythema; Female; Humans; Hypertension, Pulmonary; Pain; Sulfonamides; Ventricular Dysfunction, Right | 2006 |
Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases.
Topics: Administration, Oral; Adult; Aged; Antihypertensive Agents; Blood Pressure; Bosentan; Connective Tissue Diseases; Exercise Test; Female; Humans; Hypertension, Pulmonary; Lupus Erythematosus, Systemic; Male; Middle Aged; Mixed Connective Tissue Disease; Myositis; Prospective Studies; Scleroderma, Systemic; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Right; Walking | 2006 |
Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Dilatation, Pathologic; Echocardiography, Doppler; Exercise Test; Female; Humans; Hypertension, Pulmonary; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Thromboembolism; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2007 |
Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging; Male; Middle Aged; Pulmonary Wedge Pressure; Retrospective Studies; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right | 2008 |